BRPI0806231A2 - método para utilização da d-ribose no tratamento de arritimias cardìacas - Google Patents

método para utilização da d-ribose no tratamento de arritimias cardìacas Download PDF

Info

Publication number
BRPI0806231A2
BRPI0806231A2 BRPI0806231-5A BRPI0806231A BRPI0806231A2 BR PI0806231 A2 BRPI0806231 A2 BR PI0806231A2 BR PI0806231 A BRPI0806231 A BR PI0806231A BR PI0806231 A2 BRPI0806231 A2 BR PI0806231A2
Authority
BR
Brazil
Prior art keywords
ribose
treatment
heart
grams
arritimies
Prior art date
Application number
BRPI0806231-5A
Other languages
English (en)
Portuguese (pt)
Inventor
James D Herrick
Original Assignee
Bioenergy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioenergy Inc filed Critical Bioenergy Inc
Publication of BRPI0806231A2 publication Critical patent/BRPI0806231A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BRPI0806231-5A 2007-01-23 2008-01-23 método para utilização da d-ribose no tratamento de arritimias cardìacas BRPI0806231A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88194007P 2007-01-23 2007-01-23
US60/881,940 2007-01-23
PCT/US2008/000845 WO2008091618A1 (en) 2007-01-23 2008-01-23 Use of d-ribose to treat cardiac arrhythmias

Publications (1)

Publication Number Publication Date
BRPI0806231A2 true BRPI0806231A2 (pt) 2011-09-06

Family

ID=39264528

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0806231-5A BRPI0806231A2 (pt) 2007-01-23 2008-01-23 método para utilização da d-ribose no tratamento de arritimias cardìacas

Country Status (10)

Country Link
US (1) US8101581B2 (enExample)
EP (1) EP2120968B1 (enExample)
JP (1) JP5396387B2 (enExample)
CN (1) CN101588807B (enExample)
AT (1) ATE487485T1 (enExample)
BR (1) BRPI0806231A2 (enExample)
CA (1) CA2674717C (enExample)
DE (1) DE602008003411D1 (enExample)
ES (1) ES2352154T3 (enExample)
WO (1) WO2008091618A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
JP5396387B2 (ja) 2007-01-23 2014-01-22 バイオエナジー インコーポレイティド 心臓不整脈を治療するためのｄ−リボースの用途
CN106138071A (zh) * 2008-04-02 2016-11-23 生物能公司 核糖在对于急性心肌梗塞的第一反应中的用途
EP3411041A1 (en) 2016-02-01 2018-12-12 RiboCor, Inc. Use of ribose for treatment of subjects having congestive heart failure

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605644A (en) 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
US4719201A (en) 1985-02-07 1988-01-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia
US4824660A (en) 1985-06-06 1989-04-25 Paul S. Angello Method of determining the viability of tissue in an organism
DE4228215A1 (de) 1992-08-25 1994-03-03 Pliml Wolfgang Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen
RU2127548C1 (ru) 1996-06-26 1999-03-20 Алабовский Владимир Владимирович Способ коронарографии в эксперименте
DE19650754A1 (de) * 1996-12-06 1998-06-10 Wolfgang Dr Pliml Ribose und Schlaganfall
US6159942A (en) 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6218366B1 (en) 1998-06-19 2001-04-17 Bioenergy, Inc. Method for raising the hypoxic threshold
US6429198B1 (en) 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
US20020119933A1 (en) 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6534480B2 (en) 1999-06-17 2003-03-18 Bioenergy Inc. Compositions for increasing energy in vivo
US6511964B2 (en) 1999-09-24 2003-01-28 Bioenergy, Inc. Method for treating acute mountain sickness
US6159943A (en) 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
US6339716B1 (en) 1999-09-24 2002-01-15 Bioenergy Inc. Method for determining viability of a myocardial segment
US6703370B1 (en) 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
JP4927282B2 (ja) 1999-12-21 2012-05-09 バイオエナジー インコーポレイティド 血小板の保存のための組成物
CA2397707A1 (en) 2000-01-07 2001-07-19 Susan S. Percival Compositions for enhancing the immune response
US6525027B2 (en) 2000-01-20 2003-02-25 Bioenergy Inc. Use of ribose supplementation for increasing muscle mass and decreasing body fat in humans
US6420342B1 (en) 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
IT1317043B1 (it) * 2000-06-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
US20030212006A1 (en) 2002-05-13 2003-11-13 Seifert John G. Method for reducing free radical formation in healthy individuals undergoing hypoxic exercise and medical conditions with increased oxygen free radicals
US8486859B2 (en) 2002-05-15 2013-07-16 Bioenergy, Inc. Use of ribose to enhance plant growth
US7687468B2 (en) 2003-05-14 2010-03-30 Viacell, LLC. Rejuvenation of stored blood
US8759315B2 (en) 2003-05-14 2014-06-24 Viacell, Llc Methods for rejuvenating
US20040229205A1 (en) 2003-05-16 2004-11-18 Ericson Daniel G. Compositions for the storage of platelets
US20090197818A1 (en) 2004-01-14 2009-08-06 St Cyr John A Use Of Ribose for Recovery From Anaesthesia
WO2005107768A2 (en) 2004-04-29 2005-11-17 Bioenergy, Inc. Method for improving ventilatory efficiency
US20100099630A1 (en) 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
PT1800675E (pt) * 2005-12-23 2011-08-30 Nutricia Nv COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
US8835396B2 (en) 2006-12-15 2014-09-16 Bioenergy, Inc. Method and compositions for improving pulmonary hypertension
JP5396387B2 (ja) 2007-01-23 2014-01-22 バイオエナジー インコーポレイティド 心臓不整脈を治療するためのｄ−リボースの用途
US20090197819A1 (en) 2007-03-20 2009-08-06 Clarence Albert Johnson Compositions for improving and repairing skin
US20080312169A1 (en) 2007-03-20 2008-12-18 Clarence Albert Johnson Cosmetic use of D-ribose
US20090232750A1 (en) 2008-03-13 2009-09-17 St Cyr John A Compositions for indoor tanning
CN106138071A (zh) 2008-04-02 2016-11-23 生物能公司 核糖在对于急性心肌梗塞的第一反应中的用途
US20090286750A1 (en) 2008-05-16 2009-11-19 Kasubick Robert V Use of ribose in lessening the clinical symptoms of aberrant firing of neurons

Also Published As

Publication number Publication date
US20080176809A1 (en) 2008-07-24
EP2120968A1 (en) 2009-11-25
ES2352154T3 (es) 2011-02-16
US8101581B2 (en) 2012-01-24
CA2674717A1 (en) 2008-07-31
WO2008091618A8 (en) 2010-04-01
ATE487485T1 (de) 2010-11-15
DE602008003411D1 (de) 2010-12-23
CA2674717C (en) 2015-10-13
JP2010526884A (ja) 2010-08-05
EP2120968B1 (en) 2010-11-10
JP5396387B2 (ja) 2014-01-22
WO2008091618A1 (en) 2008-07-31
CN101588807B (zh) 2012-07-04
CN101588807A (zh) 2009-11-25

Similar Documents

Publication Publication Date Title
EP2300001A1 (en) Dronedarone for the prevention of permanent atrial fibrillation
Ermoshkin New theory of arrhythmia. Conceptual substantiation of arrhythmia mechanisms.
Tanashyan et al. Chronic cerebrovascular diseases on the background of metabolic syndrome: new approaches to treatment
BRPI0806231A2 (pt) método para utilização da d-ribose no tratamento de arritimias cardìacas
Sandler et al. Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia
Hooqenhuvze et al. Acute effects of intravenous amiodarone in patients with complex ventricular dysrhythmias
Holt et al. Intravenous amiodarone; An effective anti-arrhythmic agent
McLay et al. Arrhythmogenic right ventricular dysplasia: an uncommon cause of ventricular tachycardia in young and old?
Tsutsumi et al. General anesthesia for electroconvulsive therapy with Brugada electrocardiograph pattern
Ishizuka et al. Bilateral Subclavian Vein Occlusion in a SAPHO Syndrome Patient Who Needed an Implantable Cardioverter Defibrillator An Unusual Cause of Lead Access Failure
Samanta et al. Cardiopulmonary resuscitation in undiagnosed situs inversus totalis in emergency department: An intensivist challenge
Sadeghian et al. Short QT syndrome and idiopathic ventricular tachycardia in a 28-year-old young man: a potential disease-specific link?
RU2320328C2 (ru) Способ лечения персистирующей формы фибрилляции предсердий
Sheyin et al. High grade atrioventricular block presenting with cardiac arrest
Tichy et al. Effects Of Biological Sex On Cardiac Dysfunction During Cancer Cachexia: 215
Vera-Delgado et al. Aerobic Exercise Increases Expression Of SUR1 And SUR2A Subunits Of KATP-channels In Murine Diabetic Ventricular Cardiomyocytes.: 216
Noel et al. Cardiac conduction abnormalities and Stokes-Adams attacks in myotonic dystrophy
Weeldreyer et al. Interval Exercise Preconditioning And Cardiac Function Following Dose-dense Doxorubicin Therapy In Breast Cancer-Preliminary Results: 217
Wolfhard et al. Effects of defibrillator implantation testing on myocardial metabolism
Chung et al. Fatal cardiac thromboembolism in a patient with a pacemaker during ureteroscopic lithotripsy for ureter stone: a case report
Wright et al. Immediate effect on cardiac output of reversion to sinus rhythm from rapid arrhythmias
Rani et al. Tachycardia during cisapride treatment
Poggiali et al. A practice teaching from GIMSI (Italian Multidisciplinary Syncope Group) 2025: yoga as a treatment for recurrent vasovagal syncope
Orlando et al. Treatment of supraventricular tachyarrhythmias
Canepa-Anson et al. Effects of oral pirbuterol on haemodynamics, distribution of blood flow and lactate production during treadmill exercise in patients with chronic heart failure

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2498 DE 21-11-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.